Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May;20(4):385-92.
doi: 10.1177/1076029613486537. Epub 2013 May 7.

Confirmation of reported aspirin use in community studies: utility of serum thromboxane B2 measurement

Nicole Dodge Zantek  1 , Russell V Luepker, Sue Duval, Karen Miller, Niki Oldenburg, Alan T Hirsch
Affiliations

Confirmation of reported aspirin use in community studies: utility of serum thromboxane B2 measurement

Nicole Dodge Zantek et al. Clin Appl Thromb Hemost. 2014 May.

Abstract

Aspirin (ASA) is recommended for the prevention of cardiovascular disease; however, the compliance is low. Reported use may not reflect actual use. Serum thromboxane B2 (STxB2) measurement was evaluated to validate reported ASA use. Males aged 45 to 79 years and females aged 55 to 79 years completed a survey and STxB2 measurement (Thromboxane B2 EIA Kit; Cayman Chemical, Ann Arbor, Michigan). The 107 patients were grouped by use of ASA (56 ASA+ and 51 ASA-) and possible interfering medications (INT) such as nonsteroidal anti-inflammatory drugs. The STxB2 levels (ng/mL) were significantly lower in ASA users: ASA+ INT- 3.0 (0.7, 8.4), ASA+ INT+ 2.0 (0.8, 4.9), ASA- INT+ 176 (75, 390), and ASA- INT- 271 (199, 366). The INT use did not cause a significant difference in STxB2 levels. A STxB2 cut point of 25 ng/mL had high sensitivity (94.1%) and specificity (91.1%) for ASA use. The STxB2 was a reliable marker of ASA use and could be used to confirm ASA exposure in population-based health studies.

Keywords: NSAID; aspirin; cardiovascular prevention; compliance; nonsteroidal anti-inflammatory drug; thromboxane B2.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article:Nicole Dodge Zantek has a financial interest in Endo Health Solutions, Inc, a company which may commercially benefit from the results of this research. This interest has been reviewed and managed by the University of Minnesota in accordance with its conflict of interest policies. The other authors declare no conflict of interest with respect to authorship and/or publication of this article.

Figures

Figure 1.
Figure 1.
Comparison of serum thromboxane B2 levels in patients based on aspirin and possible interfering medication use. The boxplot shows the median (line), the 25th and 75th percentiles (box), and the upper and lower values within 1.5 times the interquartile range beyond the 25th and 75th percentile (whiskers). The dots represent outliers. ASA, aspirin; INT, possible interfering medication.
Figure 2.
Figure 2.
Receiver–operating characteristic curve of serum thromboxane B2 levels and aspirin use. The c-statistic is 0.97.
See this image and copyright information in PMC

References

    1. Antithrombotic Trialists’ Colloboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86. - PMC - PubMed
    1. Patrono C, Coller B, Dalen JE, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest. 2001;119(suppl 1):39S–63S. - PubMed
    1. Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002;162(19):2197–2202. - PubMed
    1. US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150(6):396–404. - PubMed
    1. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(1): 227–276. - PubMed

Publication types

LinkOut - more resources